This finding supports the possibility that the form of neuronal dysfunction observed in AD, and the cognitive consequences of that dysfunction, may depend on the neural network examined and the relative abundance of both Aβ and tau pathology within that network. The gene discussed is MAPT; the disease is Alzheimer disease.